These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 25393847
21. The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience. Broccoli A, Argnani L, Nanni L, Terragna C, Sabattini E, Gabrielli G, Stefoni V, Pellegrini C, Casadei B, Morigi A, Lolli G, Carella M, Coppola PE, Zinzani PL. Am J Hematol; 2021 Oct 01; 96(10):1204-1210. PubMed ID: 34245477 [Abstract] [Full Text] [Related]
22. Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases. Yu YB, Li CY, Chen CC, You JY, Chau WK, Hsu HC, Gau JP, Chen PM, Ho CH. J Chin Med Assoc; 2007 Dec 01; 70(12):551-5. PubMed ID: 18194897 [Abstract] [Full Text] [Related]
23. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V. Leukemia; 2004 Sep 01; 18(9):1476-81. PubMed ID: 15229616 [Abstract] [Full Text] [Related]
29. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia. Else M, Osuji N, Forconi F, Dearden C, Del Giudice I, Matutes E, Wotherspoon A, Lauria F, Catovsky D. Cancer; 2007 Nov 15; 110(10):2240-7. PubMed ID: 17886250 [Abstract] [Full Text] [Related]